Beranda › Penyakit Radang Usus
Uji klinis Penyakit Radang Usus yang merekrut di AS
72 studi untuk Penyakit Radang Usus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY18 studi
- Boston, MA15 studi
- Miami, FL9 studi
- Seattle, WA9 studi
- Atlanta, GA8 studi
- Orlando, FL8 studi
- Houston, TX8 studi
- Durham, NC8 studi
- Washington, DC7 studi
- St. Louis, MO7 studi
- Philadelphia, PA7 studi
- Cincinnati, OH7 studi
- Baltimore, MD6 studi
- Pittsburgh, PA5 studi
- Cleveland, OH5 studi
- Round Rock, TX5 studi
- Tyler, TX5 studi
- San Diego, CA5 studi
- Mountain View, CA5 studi
- Ann Arbor, MI5 studi
- Los Angeles, CA5 studi
- Providence, RI5 studi
- Parma, OH4 studi
- Colorado Springs, CO4 studi
- Lewisville, TX4 studi
- Fort Worth, TX4 studi
- Hartford, CT4 studi
- Milwaukee, WI4 studi
- Tampa, FL4 studi
- Garland, TX4 studi
- Chicago, IL4 studi
- Cedar Rapids, IA3 studi
- Evanston, IL3 studi
- Lancaster, CA3 studi
- Raleigh, NC3 studi
- Kendall, FL3 studi
- San Francisco, CA3 studi
- Louisville, KY3 studi
- Dayton, OH3 studi
- League City, TX3 studi
Berdasarkan negara bagian
- Arizona6 studi
- Arkansas3 studi
- California18 studi
- Colorado5 studi
- Connecticut8 studi
- Florida11 studi
- Georgia9 studi
- Illinois7 studi
- Iowa3 studi
- Kansas3 studi
- Kentucky4 studi
- Louisiana6 studi
- Maryland11 studi
- Massachusetts15 studi
- Michigan6 studi
- Minnesota3 studi
- Mississippi3 studi
- Missouri7 studi
- Nevada3 studi
- New Jersey5 studi
- New York21 studi
- North Carolina14 studi
- Ohio16 studi
- Pennsylvania11 studi
- Rhode Island5 studi
- South Carolina4 studi
- Tennessee7 studi
- Texas16 studi
- Utah3 studi
- Virginia6 studi
- Washington10 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07852273Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Menerima pesertaStudi observasional
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07619547A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487Immune Regulation in Ulcerative Colitis or Crohn s Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 75 Years · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00001184Non-nutritive Sweeteners in Inflammatory Bowel Disease
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05923073Study of DISC-0974-201 in Participants With IBD and Anemia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07368972Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06226883A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Menerima pesertaFase 3
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04685200Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07513181Observational Pharmaco-Epidemiology Research & Analysis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT03813862Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Menerima pesertaStudi observasional
1 Month – 115 Years · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT00001456A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
Menerima pesertaFase 4
3 Weeks · Wanita · Diperbarui 8 Sep 2026 · NCT07612267Familial Inflammatory Bowel Disease Early Risk
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 55 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07791862A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06274554A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Menerima pesertaStudi observasional
Usia 18 hingga 45 · Wanita · Diperbarui 11 Agu 2026 · NCT00904878BOOM-IBD2 Pivotal Clinical Trial
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06571669HB-adMSCs for the Treatment of Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07077746Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06266663Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.